RMC-5552
221014
Phase 1 small_molecule terminated
Quick answer
RMC-5552 for Glioblastoma is a Phase 1 program (small_molecule) at Revolution Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Revolution Medicines
- Indication
- Glioblastoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated